BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2693345)

  • 1. Thymocytes reacting with heterologous antibodies against GP 330 in autologous immune complex glomerulopathy (AICG) in the rat. The relation between susceptibility for AICG and anti-GP 330-binding thymocytes.
    Bagchus WM; Hoedemaeker PJ; Vos JT; Bakker WW
    Immunobiology; 1989 Oct; 179(4-5):432-44. PubMed ID: 2693345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of antigens and antibody specificities involved in Heymann nephritis.
    Kamata K; Baird LG; Erikson ME; Collins AB; McCluskey RT
    J Immunol; 1985 Oct; 135(4):2400-8. PubMed ID: 2411795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity of nephritogenic antibodies. V. Glomerular localization of anti-GP 330 and anti-GP 90 antibodies present in passive Heymann serum.
    Bagchus WM; Hoedemaeker PJ; Slegers JF; Bakker WW
    Br J Exp Pathol; 1988 Dec; 69(6):855-64. PubMed ID: 3064801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of an antigen distinct from the Heymann antigen in membranous glomerulonephritis in the mouse.
    Assmann KJ; Ronco P; Tangelder MM; Lange WP; Verroust P; Koene RA
    Lab Invest; 1989 Jan; 60(1):138-46. PubMed ID: 2642986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
    Natori Y; Hayakawa I; Shibata S
    Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats.
    Salant DJ; Belok S; Stilmant MM; Darby C; Couser WG
    Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The specificity of nephritogenic antibodies. III. Binding of anti-Fx1A antibodies in glomeruli is dependent on dual specificity.
    Bagchus WM; Vos JT; Hoedemaeker PJ; Bakker WW
    Clin Exp Immunol; 1986 Mar; 63(3):639-47. PubMed ID: 3519014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental membranous glomerulonephritis in rats induced with gp 700, a glomerular protein.
    Kamata K; Sato N; Horata E; Kobayashi Y; Okubo M
    Int Immunol; 1990; 2(11):1013-20. PubMed ID: 1707302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity of nephritogenic antibodies. II. Immune complex glomerulopathy in rats induced by heterologous antithymocyte serum.
    Bagchus WM; Donga J; Hoedemaeker PJ; Bakker WW
    Transplantation; 1984 Aug; 38(2):165-9. PubMed ID: 6235648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heymann nephritis: a model of human membranous glomerulopathy. A study of the role of additional antigens.
    van Leer EH; Ronco P; Verroust P; de Roo GM; Hoedemaeker PJ; de Heer E
    Nephrol Dial Transplant; 1992; 7 Suppl 1():1-8. PubMed ID: 1362800
    [No Abstract]   [Full Text] [Related]  

  • 13. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
    Kerjaschki D
    Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental glomerulonephritis in the isolated perfused rat kidney.
    Couser WG; Steinmuller DR; Stilmant MM; Salant DJ; Lowenstein LM
    J Clin Invest; 1978 Dec; 62(6):1275-87. PubMed ID: 372233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heymann nephritis in Lewis rats.
    Wang YM; Lee VWS; Wu H; Harris DCH; Alexander SI
    Curr Protoc Immunol; 2015 Apr; 109():15.29.1-15.29.6. PubMed ID: 25845564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenetic concepts of membranous glomerulopathy (MGN).
    Kerjaschki D
    J Nephrol; 2000; 13 Suppl 3():S96-100. PubMed ID: 11132040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the pathogenic roles of antigens isolated from renal tubular cells in the classical Heymann nephritis].
    Yamagata K; Koyama A; Kobayashi M; Narita M
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1053-60. PubMed ID: 2287097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of experimental membranous glomerulonephritis in rats by an anti-MHC class II antibody.
    Hasegawa Y; Kaneoka H; Tanaka T; Ogahara S; Matsumae T; Noda R; Yoshitake K; Murata T; Naito S
    Nephron; 2001 Jul; 88(3):233-40. PubMed ID: 11423754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephritogenicity and immunocytochemical localization of the 70-kilodalton glycoprotein subunit (gp70) of Heymann antigen.
    Singh AK; Schwartz MM
    Clin Immunol Immunopathol; 1988 Jul; 48(1):61-77. PubMed ID: 3289803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.